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members of babies in the NICU will further reduce the like-
lihood of introducing community-associated pathogens into
the NICU.14th International Congress on Infectious Diseases (ICID) Abs
ﬂowing with improved insecticides and drugs to replace
those that succumb to resistance, as well as to develop new
tools, including safe and effective drugs and vaccines that
block malaria transmission. Prospects for malaria eradica-
tion may be jeopardized by the apparent recent emergence
of artemisinin-resistant falciparum malaria in Southeast
Asia.
doi:10.1016/j.ijid.2010.02.1886
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As infant and child mortality declines in many developing
countries, neonatal mortality becomes the dominant com-
ponent of all child mortality, now constituting about 40% of
child deaths. As attention is focused on this problem, it is
becoming clear that, in the high mortality countries, neona-
tal mortality rates are being systematically underestimated,
especially in the poorest, most marginalized communities.
Data on the causes of neonatal deaths in the community are
seriously inadequate, as deaths occur outside the health ser-
vice, and post mortem questionnaires are very difﬁcult to
interpret in this age group. Studies that examined the inci-
dence and mortality due to neonatal sepsis were reviewed.
We sought to determine the relationship between the neona-
tal mortality rate and the proportion of neonatal deaths
due to infection. From a review of 32 community based
studies published since 1990, between 8% and 80% of all
neonatal deaths in different regions of the developing world
are reported as being due to infectious causes. Similar wide
variability is seen in the incidence of clinical neonatal sep-
sis, with reported rates varying from 49 per 1000 live births
in rural Guatemala to as high as 170 per 1000 live birthsin
rural India. The ﬁeld of neonatal mortality, and speciﬁcally
neonatal sepsis, in developing countries is obscured by a
lack of credible data. Neonatal sepsis rates are confounded
by lack of clear clinical deﬁnitions, and even neonatal mor-
tality rates are very unclear. Without any clear means of
determining the cause of community neonatal deaths, the
contribution of sepsis to overall mortality is equally unclear.
The need for new and innovative research in this ﬁeld is
overwhelming.
doi:10.1016/j.ijid.2010.02.1887
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Health-care associated infections remain a major prob-
em in the neonatal intensive care unit (NICU), resulting
n signiﬁcant morbidity and mortality. Speciﬁcally, blood-
tream infections have been associated with adverse
eurodevelopmental outcomes among preterm infants with
irth weight <1000 grams. In addition, these infections are
ssociated with prolonged duration of hospitalization among
urvivors and increased cost of neonatal health care. It is
lear that preventive strategies are urgently needed.
Many bloodstream infections in the NICU are associated
ith the use of central venous catheters, and implemen-
ation of evidence-based measures as well as bundles
as reduced their occurrence. Nevertheless, much work
emains. Candidal infections have become more prevalent
n the NICU, and ﬂuconazole prophylaxis is being recom-
ended and used to prevent candidiasis among infants with
irth weight <1000 grams. Although ﬂuconazole prophylaxis
as reduced invasive candidal infections, the underlying risk
actors that result in Candida becoming a more common
athogen remain, namely the overuse of antibiotics espe-
ially the third generation cephalosporins. In addition, the
se of H2 blocker also has contributed to Candidal coloniza-
ion and late onset sepsis. Recent results of randomized
linical trials have shown beneﬁcial effects of probiotics
or prevention of necrotizing enterocolitis and lactoferrin
or prevention of late onset sepsis. Finally, the need to
accinate not only our preemies but also staff and familyoi:10.1016/j.ijid.2010.02.1889
